85-1460-47　A77 1726-d4 (N-(4-Trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamide-d4, 2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-beuteamide-d4, LEF-M-d4) 1mg　A0001-67G

特徴

• The active metabolite of Leflunomide, a potent disease-modifying antirheumatic drug used in the treatment of rheumatoid arthritis. LEF-M interferes with dendritic cell function.
• Source:Synthetic
• Purity:~90%
• Form:Supplied as a white solid
• Solubility:DMSO (Heated)
• Melting Point:220-223ºC
• Method for Determining Identity:Proton NMR and Mass Spectroscopic Analysis
• TLC Conditions:SiO2: Ethyl Acetate: Hexane: Acetic acid; 7ml: 3ml: 5 drops; Visualized with UV and AMCS; Single spot; Rf=0.35.
• Storage and Stability:May be stored at RT for short-term only. Long-term storage is recommended at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.

仕様

• Size：1mg
• Source Antigen：Synthetic
• Grade：Highly Purified
• Purity：~90%
• Form：Supplied as a white solid
• Molecular Formula：C12H5D4F3N2O2
• Molecular Weight Non Ab：274.23
• EU Commodity Code：38220090
• この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
• 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]